FDA Approved: * July 27, 2018 Pharm Company: *WATSON LABS TEVA Category:Multiple Sclerosis
Teriflunomide, sold under the brand name Aubagio, is the active metabolite of leflunomide. Teriflunomide was investigated in the Phase III clinical trial TEMSO as a medication for multiple sclerosis (MS). The study was completed in July 2010. 2-year results were positive. However, the subsequent TENERE head-to-head comparison trial reported that "although permanent discontinuations [of therapy] were substantially less common among M...
* May have multiple approval dates, manufacturers, or labelers.